Related Experiment Video
Updated: Jun 15, 2026

A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms
Jean L Mbisa1, Wei Bu, Vinay K Pathak
1HIV Drug Resistance Program, National Cancer Institute at Frederick, P.O. Box B, Building 535, Room 334, Frederick, MD 21702-1201, USA.
Insights
APOBEC3F (A3F) and APOBEC3G (A3G) inhibit HIV-1 replication by mutating viral DNA. A3F is more potent than A3G at blocking viral DNA integration through distinct mechanisms involving DNA processing and binding affinity.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- APOBEC3F (A3F) and APOBEC3G (A3G) are host restriction factors that inhibit HIV-1 replication.
- Their antiviral activity involves cytidine deamination, leading to lethal mutations in the viral genome.
- Previous research showed A3G blocks viral DNA transfer and provirus establishment.
Purpose of the Study:
- To investigate if A3F interferes with HIV-1 provirus formation similarly to A3G.
- To compare the mechanisms by which A3F and A3G inhibit HIV-1 proviral DNA integration.
- To determine the role of the catalytic domain and DNA binding affinity in the distinct functions of A3F and A3G.
Main Methods:
- Southern blot analysis to examine viral cDNA processing.
- Assessing inhibition of viral DNA synthesis and integration.
- Evaluating the impact of functional catalytic domains on antiviral activity.
- Measuring binding affinity of A3F and A3G to viral DNA templates.
Main Results:
- Both A3F and A3G inhibit HIV-1 DNA synthesis and integration, with A3F being more potent in preventing integration.
- A3G causes a 6-bp extension at the 3'-LTR U5 end, hindering integration.
- A3F inhibits integration by reducing 3' processing at both U5 and U3 ends.
- A functional C-terminal catalytic domain is more critical for A3G than A3F.
- A3F exhibits greater binding affinity for viral 3'-LTR dsDNA than A3G.
Conclusions:
- A3F and A3G employ distinct mechanisms to prevent HIV-1 DNA integration.
- Differences in target specificity and/or dsDNA binding affinity contribute to their distinct antiviral functions.
- A3F is a more potent inhibitor of HIV-1 provirus formation than A3G due to its unique mechanism of action.
Abstract:
APOBEC3F (A3F) and APBOBEC3G (A3G) both are host restriction factors that can potently inhibit human immunodeficiency virus type 1 (HIV-1) replication. Their antiviral activities are at least partially mediated by cytidine deamination, which causes lethal mutations of the viral genome. We recently showed that A3G blocks viral plus-strand DNA transfer and inhibits provirus establishment in the host genome (J. L. Mbisa, R. Barr, J. A. Thomas, N. Vandegraaff, I. J. Dorweiler, E. S. Svarovskaia, W. L. Brown, L. M. Mansky, R. J. Gorelick, R. S. Harris, A. Engelman, and V. K. Pathak, J. Virol. 81:7099-7110, 2007). Here, we investigated whether A3F similarly interferes with HIV-1 provirus formation. We observed that both A3F and A3G inhibit viral DNA synthesis and integration, but A3F is more potent than A3G in preventing viral DNA integration. We further investigated the mechanisms by which A3F and A3G block viral DNA integration by analyzing their effects on viral cDNA processing using Southern blot analysis. A3G generates a 6-bp extension at the viral U5 end of the 3' long terminal repeat (3'-LTR), which is a poor substrate for integration; in contrast, A3F inhibits viral DNA integration by reducing the 3' processing of viral DNA at both the U5 and U3 ends. Furthermore, we demonstrated that a functional C-terminal catalytic domain is more critical for A3G than A3F function in blocking HIV-1 provirus formation. Finally, we showed that A3F has a greater binding affinity for a viral 3'-LTR double-stranded DNA (dsDNA) oligonucleotide template than A3G. Taking these results together, we demonstrated that mechanisms utilized by A3F to prevent HIV-1 viral DNA integration were different from those of A3G, and that their target specificities and/or their affinities for dsDNA may contribute to their distinct mechanisms.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Retrovirus Life Cycles
Size and Structure of Viral Genomes

